Results 261 to 270 of about 50,400 (305)
Some of the next articles are maybe not open access.

Dementia with Lewy Bodies

Journal of the American Geriatrics Society, 1998
In the last decade, a new degenerative dementia, probably the second most common after Alzheimer's disease (AD), has been increasingly recognized under the consensus name of dementia with Lewy bodies (DLB). This article reviews current clinical, genetic, and pathological DLB data and indicates directions for future research.
E, Gómez-Tortosa   +3 more
openaire   +2 more sources

Rivastigmine: Dementia with Lewy Bodies

Hospital Pharmacy, 2016
This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or
Kimberly A, Madson, Sherrill, Brown
openaire   +2 more sources

Frontotemporal Dementia Mimicking Dementia With Lewy Bodies

Cognitive and Behavioral Neurology, 2008
Some patients with frontotemporal dementia (FTD) have concomitant extrapyramidal symptoms and psychosis and may simultaneously meet consensus criteria for FTD and for dementia with Lewy bodies (DLB). Clinicopathologic studies are helpful in understanding the underlying neurodegenerative process in such cases.To describe clinical and pathologic features
Daniel O, Claassen   +5 more
openaire   +2 more sources

Dementia with Lewy Bodies

Seminars in Neurology, 2013
Dementia with Lewy bodies (DLB) is a synucleinopathy that is clinically distinct from Alzheimer's disease, associated with cognitive decline, fluctuations in alertness and cognition, visual hallucinations, and parkinsonism. Other clinical symptoms that can occur with DLB include dysautonomia and sleep disorders such as rapid-eye-movement sleep behavior
openaire   +2 more sources

Dementia with Lewy Bodies: Neuropathology

Journal of Geriatric Psychiatry and Neurology, 2002
The pathologic substrate of the clinical syndrome of dementia with Lewy bodies (DLB) remains to be determined. Only a few prospective clinicopathologic studies have been reported. In those reports, most cases of DLB had neocortical or limbic Lewy bodies and Alzheimer-type pathology below threshold for diagnosis of Alzheimer's disease.
openaire   +2 more sources

[Dementia with Lewy bodies].

Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2005
"Dementia with Lewy bodies (DLB)" was proposed at the first international workshop in 1995. It has received much attention since we had proposed "Lewy body disease" in 1980 and "diffuse Lewy body disease" in 1984. In the CDLB guidelines, which were reported in 1996, the clinical and pathological diagnostic criteria for DLB were shown for the first time.
Kenji, Kosaka   +3 more
openaire   +3 more sources

Dementia with Lewy bodies

2020
Abstract Lewy bodies are eosinophilic spherical neuronal intracytoplasmic inclusions. Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia. Clinical manifestations of DLB include cognitive impairment, extra-pyramidal symptoms, neuropsychiatric symptoms, and autonomic dysfunction.
Anto P. Rajkumar, Dag Aarsland
openaire   +1 more source

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

Neurology, 1996
I. McKeith   +24 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy